D-DOPA, pharmaceutically acceptable salts thereof, and methods o

Details D-DOPA, pharmaceutically acceptable salts thereof, and methods o D-DOPA, pharmaceutically acceptable salts thereof, and methods o

1988-03-02

1989-09-05

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31195

Patent

active

048639621

ABSTRACT:
The present invention is directed to a method of treating Parkinson's disease. More particularly, the present invention utilizes D-DOPA or the racemic mixture of D,L-DOPA, or pharmaceutically acceptable salts thereof, in an anti-parkinsonism effective amount for the treatment of Parkinson's disease.

REFERENCES:
patent: Re29892 (1979-01-01), Bayne
patent: 3253023 (1966-05-01), Wysong
patent: 3405159 (1963-10-01), Krieger et al.
patent: 3557292 (1971-01-01), Bartholini
patent: 3911137 (1975-10-01), Miki et al.
patent: 4409233 (1983-10-01), Tsukada et al.
patent: 4424235 (1984-01-01), Sheth et al.
patent: 4497826 (1985-02-01), Narabayashi et al.
Chem. Abst. 88-124414j, (1988).
Physician's Desk Reference, 41st edition, 1987, pp. 1336-1337.
"Fitness," Parade Magazine, Mar. 1, 1987.
Yamada et al: "Studies on Optically Active Amino Acids".
Lloyd et al: Journal of Pharm. and Exp. Ther., vol. 195: No. 3.
Lovenberg et al, J. Biol. Chem., vol. 237, No. 1, 1962.

Affiliated with

Also associated with

Rating

D-DOPA, pharmaceutically acceptable salts thereof, and methods o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with D-DOPA, pharmaceutically acceptable salts thereof, and methods o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and D-DOPA, pharmaceutically acceptable salts thereof, and methods o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-243902